Hepatobiliary Cancer Surveillance Program

[Siriphak Pongthai]

Hepatobiliary cancer is the most common cancer reported in Thailand. . Hepatobiliary cancer can be classified into liver cancer (hepatocellular carcinoma or HCC), gallbladder cancer, and bile ducts cancer (intrahepatic and extrahepatic cholangiocarcinoma, or CCA). Patients with hepatobiliary cancer have very low survival rates. Even CCA is a rare tumor, Thailand is reported the highest incident of CCA in the world, high occurrences in the North and Northeastern regions of Thailand.

Therefore, this surveillance program aims to track trends of persons diagnosed with hepatobiliary cancer, to collect and follow-up all previously diagnosed hepatobiliary cancer patients until death, and to reduce the mortality rate of hepatobiliary cancer patients.

Please fell free to comment and suggest 🙂

[ABDILLAH FARKHAN]

Thank you for presenting us the importance of Hepatobiliary Cancer Surveillance. Your presentation enriches my insight about surveillance applied for NCDs.

It is true to mention that in a disease with slow progress, the behavioral, physical, and biological risk factors information can help us to estimate the burden.

Best.

[Tanatorn Tilkanont]

Thank you for a comprehensive surveillance system. There is a high incidence of hepatobiliary cancer in Thailand. I believe that your surveillance system will be very useful to public health.
As you mentioned in the data flow diagram, I understand that you mean the data from the Ministry of public health could be shared with sponsors once there’s an official agreement made. By sharing data with sponsors like Pharmaceutical companies, it is very essential for oncology trials. The trials could use the data in terms of trial project design and for further hypotheses of new drugs/trials. I expected that it does not just benefit public health but also shape clinical trial design in the future.

Great Presentation.

[Tanyawat Saisongcroh]

Great talk and thank you for sharing a very informative and important topic here.

For the evaluation indicators, I might suggest additional “consistency”, since it’s a national surveillance and data will be collected from different hospital databases, you might need to ensure that there’s a standard protocol that all users can follow.

[Author]

Posts